Baird Financial Group
AXDX

Baird Financial Group’s Accelerate Diagnostics AXDX Stock Holding History

Baird Financial Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,003
Closed -$24.3K – 1710
2023
Q2 		$24.3K Hold
3,003
– – ﹤0.01% 1677
2023
Q1 		$21K Hold
3,003
– – ﹤0.01% 1676
2022
Q4 		$21K Hold
3,003
– – ﹤0.01% 1673
2022
Q3 		$46K Hold
3,003
– – ﹤0.01% 1685
2022
Q2 		$30K Sell
3,003
-171,152
-98% -$1.51M ﹤0.01% 1760
2022
Q1 		$2.51M Buy
174,155
+23,348
+15% +$665K 0.01% 814
2021
Q4 		$7.87M Buy
150,807
+40,017
+36% +$2.23M 0.02% 496
2021
Q3 		$6.46M Buy
110,790
+7,195
+7% +$469K 0.02% 522
2021
Q2 		$8.35M Buy
103,595
+5,121
+5% +$407K 0.02% 464
2021
Q1 		$8.19M Buy
98,474
+735
+0.8% +$74.6K 0.02% 448
2020
Q4 		$7.41M Buy
97,739
+2,600
+3% +$233K 0.02% 447
2020
Q3 		$10.1M Sell
95,139
-1,335
-1% -$185K 0.03% 362
2020
Q2 		$14.6M Buy
96,474
+42,380
+78% +$4.18M 0.06% 291
2020
Q1 		$4.51M Buy
54,094
+9,414
+21% +$1.32M 0.02% 467
2019
Q4 		$7.55M Buy
44,680
+2,691
+6% +$444K 0.03% 444
2019
Q3 		$7.8M Buy
41,989
+2,192
+6% +$424K 0.03% 398
2019
Q2 		$9.11M Buy
39,797
+572
+1% +$112K 0.04% 379
2019
Q1 		$8.24M Sell
39,225
-4,938
-11% -$926K 0.05% 346
2018
Q4 		$5.08M Buy
44,163
+27,989
+173% +$4.15M 0.03% 413
2018
Q3 		$3.55M Buy
16,174
+738
+5% +$163K 0.02% 528
2018
Q2 		$3.44M Buy
15,436
+548
+4% +$123K 0.02% 516
2018
Q1 		$3.4M Buy
14,888
+5,026
+51% +$1.32M 0.02% 502
2017
Q4 		$2.58M Buy
+9,862
New +$2.31M 0.02% 555
2016
Q4 		– Sell
-746
Closed -$203K – 1195
2016
Q3 		$203K Buy
+746
New +$165K ﹤0.01% 1144

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
CI
Chartist Inc Seal Beach, California $160M AUM 15.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baird Financial Group's AXDX Position: Q3 2023 in Review

Baird Financial Group sold out of Accelerate Diagnostics (AXDX) in Q3 2023, closing a stake of 3,003 shares — an estimated $24.3K sold.

Baird Financial Group first reported a position in AXDX in Q3 2016 and held it in 24 quarters. The position peaked at $14.6M in Q2 2020. 38 funds tracked by Wall St. Rank hold AXDX as of Q3 2023.

  • Baird Financial Group reported no remaining Accelerate Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Baird Financial Group sold 3,003 Accelerate Diagnostics shares in Q3 2023, an estimated $24.3K.
  • Baird Financial Group first reported a position in Accelerate Diagnostics in Q3 2016 and held it in 24 quarters.
  • Baird Financial Group's Accelerate Diagnostics position peaked at $14.6M in Q2 2020.
  • 38 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2023.

Based on Baird Financial Group's 13F filing for Q3 2023, filed 13 Nov 2023.